The capacity of rat haemopoietic colony-forming units (CFU) to produce differentiated progeny has been investigated. The colony differential of primary colonies in the spleen was dependent on whether spleen or bone marrow was used as the l source of the CFU. However, both bone marrow and spleen derived colonies showed increases in the proportion of undifferentiated colonies and in the number of both surface and total colonies as the time of colony development was extended. On the other hand, the colony differential of primary colonies in the bone marrow was independent of the source of the CFU. Colonies in the bone marrow did not change in number or histological type as the period of colony development was extended. Since differentiation of CFU was more complete in the bone marrow compared to the spleen, it is suggested that the bone marrow in rats represents the better site to study stem cell differentiation. Calculations based on the results of individual colony transplant experiments suggest that approximately 30% of rat bone marrow CFU do not form colonies in the spleen because they differentiate.

Keywords:
Bone marrow colonies, Colony-forming units, Haemopoiesis, Spleen colonies, Stem cell differentiation
This content is only available via PDF.
© 1974 S. Karger AG, Basel
1974
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.